Registration Requirements for Importers and Manufacturers of Prescription Drug Products Containing Ephedrine, Pseudoephedrine, or Phenylpropanolamine

Summary

The Combat Methamphetamine Epidemic Act of 2005 requires the Drug Enforcement Administration (DEA) to establish annual import and manufacturing quotas for ephedrine, pseudoephedrine, and phenylpropanolamine due to new regulations. The current registration provisions are inadequate because they do not cover all manufacturers and distributors of these chemicals, which are used to produce prescription drugs.